SciFluor Life Sciences Company
SciFluor Life Sciences is an Allied Minds funded company with a late-stage fluorination technology that improves drug properties such as metabolic stability, potency, bioavailability, and blood-brain-barrier penetration. The company's late-stage fluorination technology is licensed exclusively from Harvard University. SciFluor's technology enables end-stage or any-stage fluorination of a wide variety of organic compounds.
Employee Number:
1-10
Funding Status:
Early Stage Venture
Headquarters:
Boston, Massachusetts, United States
Technology:
Neurological Disorders
Estimated Revenue:
$1M to $10M
Founded Date:
2011-01-01
Last Funding Type:
Series B
Total Funding:
35000000
Industry:
BioTech